
Evaluating Adherence to Dilated Eye Examination Recommendations Among Patients with Diabetes, Combined with Patient and Provider Perspectives
Evaluating Adherence to Dilated Eye Examination Recommendations Among Patients with Diabetes, Combined with Patient and Provider Perspectives
Maxine D. Fisher , PhD, Yamina Rajput , MS, Tao Gu , PhD, Joseph R. Singer , MD, Amanda R. Marshall , BS, Seonyoung Ryu , PharmD, John Barron , PharmD, and Catherine MacLean , MD, PhD
Director, Real World Evidence, Vector Oncology, Memphis, TN, and was with HealthCore at the time of the study
Chief Medical Value Officer, Hospital for Special Surgery, New York, NY, and was with Anthem at the time of the study.
Maxine D. Fisher, Director, Real World Evidence, Vector Oncology, Memphis, TN, and was with HealthCore at the time of the study;
Received 2016 Jan 22; Accepted 2016 May 20.
Copyright 2016 by Engage Healthcare Communications, LLC
Diabetes mellitus remains the leading cause of new cases of blindness among US adults. Routine dilated eye examinations can facilitate early detection and intervention for diabetes-related eye disease, providing an opportunity to reduce the risk for diabetes-related blindness in working-aged Americans. The Healthcare Effectiveness Data and Information Set (HEDIS) established criteria for performing dilated eye examination in patients with diabetes.
To obtain information about adherence and nonadherence to diabetic eye examinations among insured patients to understand the barriers to routine dilated eye examinations, and to identify ways to improve the quality of care for these patients.
This retrospective claims analysis is based on administrative claims from the HealthCore Integrated Research
Continue
reading